Study devises risk index to identify people with cancer who are at low risk of complication if treated with empiric antibiotics for febrile neutropenia
Treatment of cytomegalovirus pneumonia with high-dose acyclovir
Piperacillin or ticarcillin plus amikacin: A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients
Hepatitis in patients with acute nonlymphocytic leukemia
Potential of imipenem as single-agent empiric antibiotic therapy of febrile neutropenic patients with cancer
